Novartis AG ADS (NVS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

LICHTSTRASSE 35 BASEL, SWITZERLAND CH 4056

Novartis is a pharmaceutical group based in Switzerland. Co. specializes in the research, development, manufacturing and marketing of healthcare products. Co.'s portfolio includes medicines, eyecare, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Co.'s operations are organized along five business divisions: Pharmaceuticals (patent-protected prescription medicines); Alcon (vision care products); Sandoz (generic parmaceuticals); Vaccines and Diagnostics (Human vaccines and blood-testing diagnostics); and Consumer Health (Over-the-counter medicines; veterinary products for farm and companion animals; and contact lenses and lens-care products).

Data based on most recent fiscal year report
Market Cap189.532 Billion Shares Outstanding2.366 Billion Avg Volume3.27 Million
1-Yr BETA vs S&P TR0.426 Current Ratio1.04 Quick Ratio0.78
View SEC Filings from NVS instead.
Q3 2019 All Institutions Hedge Funds 1
To trade NVS now:
Filers who had this stock in their top 10: 11 0 (0.0%)
13F Filers holding this stock: 1033 67 (7.0%)
Aggregate 13F shares on 09/30/2019: 237.49 Million 17.587 Million
Aggregate 13F shares on 06/30/2019: 256.579 Million 20.586 Million
Percent change: -7.44% -14.57%
Funds creating new positions: 64 9
Funds Adding to an existing position: 336 24
Funds closing out their position: 67 13
Funds reducing their position: 430 22
Heat Map Ranking for 06/30/2019 104
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding NVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments